Standard & Poor's Guide to Health Care, Pharmaceutical & BioTech Stocks (Standard & Poor's Stock Sector Guides) - Softcover

Standard & Poor'S, N/A

9780071384131: Standard & Poor's Guide to Health Care, Pharmaceutical & BioTech Stocks (Standard & Poor's Stock Sector Guides)

Softcover

ISBN 10: 0071384138 ISBN 13: 9780071384131

Publisher: McGraw-Hill Education, 2003

Standard and Poor's has been the leading brand in financial information and analysis around the world. Brokers, investment bankers, and other Wall Street professionals have relied upon S&P's unparalleled financial analysis for over 140 years. Their stock reports and ratings are among the most-respected in the industry. Now S&P's celebrated stock reports are collected for the top-rated stocks in the S&P 1500 composite index for each of today's five hottest stock sectors. Finance; Technology; Health Care, Pharmaceutical and Biotechnology; Energy; Communications and Telecom; The industries in these sectors include some of the fastest growing stocks around, and each of them include stocks assigned the prestigious 5-Star rating by S&P's top analysts. 65 percent of the 5-Star rankings allotted to stocks in S&P's 1500 composite index were assigned to stocks in one these 5 sectors! Included in each book are S&P's exclusive stock reports for the top-rated companies in each industry in the sector. Each book will also contain S&P analysts' valuable analysis of the sector as a whole and exclusive advice on how to evaluate stocks in each industry in the sector.

"synopsis" may belong to another edition of this title.

About the Author:

Standard & Poor's, a division of the McGraw-Hill Companies, is the nation's leading securities information company. It provides a broad range of services, including their respected bond and stock ratings, advisory services, and data guides. Its S&P 500 stock index is among the most closely-watched and widely-reported gauges of stock market activity. S&P products are marketed around the world and are used by both financial professionals and individual investors.

"About this title" may belong to another edition of this title.